Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 263–263 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Thyroid disorders and thyrotoxicosis: 5 case reports
Case report
  • 13 Downloads

Reference

  1. Ma C, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research 7: 1214-1220, No. 7, Jul 2019. Available from: URL: http://doi.org/10.1158/2326-6066.CIR-18-0613 - ChinaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations